Occult infection and resistance of anaemia to rHuEpo therapy in renal failure.
Muirhead
N
N
University of Western Ontario, London, Canada.
Hodsman
A B
AB
D000038:Abscess / Q000150:complications / Q000628:therapy; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007239:Infections / Q000150:complications* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D006435:Renal Dialysis
D011994:Recombinant Proteins; D004921:Erythropoietin